{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:07:13Z","timestamp":1790885233475,"version":"4.1.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>FGF5 and FGF18 are key factors in the regulation of the hair follicle cycle. FGF5 is overexpressed during the late anagen phase and serves as a crucial regulatory factor that promotes the anagen-to-catagen transition in the hair follicle cycle. FGF18, which is overexpressed during the telogen phase, mainly regulates the hair follicle cycle by maintaining the telogen phase and inhibiting the entry of hair follicles into the anagen phase. The inhibition of FGF5 may prolong the anagen phase, whereas the inhibition of FGF18 may promote the transition of the hair follicles from the telogen phase to the anagen phase. In the present study, we used siRNA to suppress FGF5 or FGF18 expression as a way to inhibit the activity of these genes. Using qPCR, we showed that FGF5-targeting siRNA modified by cholesterol was more effective than the same siRNA bound to a cell-penetrating peptide at suppressing the expression of FGF5 both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. We then investigated the effects of the cholesterol-modified siRNA targeting either FGF5 or FGF18 on the hair follicle cycle in a depilated area of the skin on the back of mice. The cholesterol-modified siRNA, delivered by intradermal injection, effectively regulated the hair follicle cycle by inhibiting the expression of FGF5 and FGF18. More specifically, intradermal injection of a cholesterol-modified FGF5-targeted siRNA effectively prolonged the anagen phase of the hair follicles, whereas intradermal injection of the cholesterol-modified FGF18-targeted siRNA led to the mobilization of telogen follicles to enter the anagen phase earlier. The inhibitory effect of the cholesterol-modified FGF18-targeted siRNA on FGF18 expression was also evaluated for a topically applied siRNA. Topical application of a cream containing the cholesterol-modified FGF18-targeted siRNA on a depilated area of the skin of the back of mice revealed comparable inhibition of FGF18 expression with that observed for the same siRNA delivered by intradermal injection. These findings suggested that alopecia could be prevented and hair regrowth could be restored either through the intradermal injection of cholesterol-modified siRNA targeting FGF5 or FGF18 or the topical application of FGF18 siRNA.<\/jats:p>","DOI":"10.3389\/fphar.2021.666860","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:40:31Z","timestamp":1625640031000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Suppression of FGF5 and FGF18 Expression by Cholesterol-Modified siRNAs Promotes Hair Growth in Mice"],"prefix":"10.3389","volume":"12","author":[{"given":"Jungang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuenan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4155\/tde.15.2","article-title":"Cationic Cell-Penetrating Peptides as Vehicles for siRNA Delivery","volume":"6","author":"Beloor","year":"2015","journal-title":"Ther. Deliv."},{"key":"B2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.biomaterials.2017.08.036","article-title":"Polymeric Nanoparticles of siRNA Prepared by a Double-Emulsion Solvent-Diffusion Technique: Physicochemical Properties, Toxicity, Biodistribution and Efficacy in a Mammary Carcinoma Mice Model","volume":"145","author":"Ben David-Naim","year":"2017","journal-title":"Biomaterials"},{"key":"B3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2004.08.012","article-title":"Self-renewal, Multipotency, and the Existence of Two Cell Populations within an Epithelial Stem Cell Niche","volume":"118","author":"Blanpain","year":"2004","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/ccid.s123401","article-title":"Promotion of Anagen, Increased Hair Density and Reduction of Hair Fall in a Clinical Setting Following Identification of FGF5-Inhibiting Compounds via a Novel 2-stage Process","volume":"10","author":"Burg","year":"2017","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jconrel.2014.01.006","article-title":"Topical Delivery of siRNA into Skin Using SPACE-Peptide Carriers","volume":"179","author":"Chen","year":"2014","journal-title":"J. Controlled Release"},{"key":"B6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2148-13-34","article-title":"Characterization of Hairless (Hr) and FGF5 Genes Provides Insights into the Molecular Basis of Hair Loss in Cetaceans","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Evol. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jconrel.2012.12.030","article-title":"Gene Silencing Following siRNA Delivery to Skin via Coated Steel Microneedles: In Vitro and In Vivo Proof-Of-Concept","volume":"166","author":"Chong","year":"2013","journal-title":"J. Controlled Release"},{"key":"B8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/exd.13881","article-title":"Exploring the Potential for Rosacea Therapeutics of siRNA Dispersion in Topical Emulsions","volume":"28","author":"Colombo","year":"2019","journal-title":"Exp. Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.0022-202X.2005.23672.x","article-title":"Dermal Delivery of Topically Applied Oligonucleotides via Follicular Transport in Mouse Skin","volume":"124","author":"Dokka","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-0716-1298-9_18","article-title":"Cell-Penetrating Peptides Delivering siRNAs: An Overview","volume":"2282","author":"Falato","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.gene.2015.09.034","article-title":"Fibroblast Growth Factor 5-short (FGF5s) Inhibits the Activity of FGF5 in Primary and Secondary Hair Follicle Dermal Papilla Cells of cashmere Goats","volume":"575","author":"He","year":"2016","journal-title":"Gene"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/jid.2010.426","article-title":"Use of Self-Delivery siRNAs to Inhibit Gene Expression in an Organotypic Pachyonychia Congenita Model","volume":"131","author":"Hickerson","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"10648","DOI":"10.1073\/pnas.1402862111","article-title":"FGF5 Is a Crucial Regulator of Hair Length in Humans","volume":"111","author":"Higgins","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/jcp.10369","article-title":"Decapeptide with Fibroblast Growth Factor (FGF)-5 Partial Sequence Inhibits Hair Growth Suppressing Activity of FGF-5","volume":"197","author":"Ito","year":"2003","journal-title":"J. Cel. Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"650","DOI":"10.5713\/ajas.17.0517","article-title":"Cashmere Growth Control in Liaoning cashmere Goat by Ovarian Carcinoma Immunoreactive Antigen-like Protein 2 and Decorin Genes","volume":"31","author":"Jin","year":"2018","journal-title":"Asian-australas J. Anim. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.0022-202X.2005.23693.x","article-title":"Comprehensive Analysis of FGF and FGFR Expression in Skin: FGF18 Is Highly Expressed in Hair Follicles and Capable of Inducing Anagen from Telogen Stage Hair Follicles","volume":"124","author":"Kawano","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/jhered\/esm072","article-title":"Four Independent Mutations in the Feline Fibroblast Growth Factor 5 Gene Determine the Long-Haired Phenotype in Domestic Cats","volume":"98","author":"Kehler","year":"2007","journal-title":"J. Hered."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/jid.2011.490","article-title":"Hair Cycle Resting Phase Is Regulated by Cyclic Epithelial FGF18 Signaling","volume":"132","author":"Kimura-Ueki","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1039\/c2mb25467k","article-title":"Cell-penetrating Peptides (CPPs) as a Vector for the Delivery of siRNAs into Cells","volume":"9","author":"Nakase","year":"2013","journal-title":"Mol. Biosyst."},{"key":"B20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/ph13100294","article-title":"Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside","volume":"13","author":"Sajid","year":"2020","journal-title":"Pharmaceuticals"},{"key":"B21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11427-018-9438-y","article-title":"siRNA Therapeutics: a Clinical Reality","volume":"63","author":"Saw","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic Silencing of an Endogenous Gene by Systemic Administration of Modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1242\/jcs.107.2.693","article-title":"Protein Composition of Cornified Cell Envelopes of Epidermal Keratinocytes","volume":"107","author":"Steven","year":"1994","journal-title":"J. Cel. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1124\/jpet.111.180042","article-title":"Therapeutic Effects on Atopic Dermatitis by Anti-RelA Short Interfering RNA Combined with Functional Peptides Tat and AT1002","volume":"338","author":"Uchida","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/nbt1339","article-title":"Mechanisms and Optimization of In Vivo Delivery of Lipophilic siRNAs","volume":"25","author":"Wolfrum","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/age.12656","article-title":"A Nonsense Mutation in the FGF5 Gene Is Associated with the Long-Haired Phenotype in Domestic guinea Pigs (Cavia porcellus )","volume":"49","author":"Yu","year":"2018","journal-title":"Anim. Genet."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.666860\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:40:33Z","timestamp":1625640033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.666860\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":26,"alternative-id":["10.3389\/fphar.2021.666860"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.666860","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"article-number":"666860"}}